|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期2000-01-11 |
靶点- |
作用机制- |
|
|
|
非在研适应症- |
最高研发阶段临床前 |
首次获批国家/地区- |
首次获批日期- |
靶点- |
作用机制- |
|
|
|
非在研适应症- |
最高研发阶段临床前 |
首次获批国家/地区- |
首次获批日期- |
A Phase 2, Double-Masked, Randomized, Vehicle-controlled Trial Evaluating the Efficacy and Safety of Cevimeline Ophthalmic Solution Compared to Vehicle in Subjects With Dry Eye Disease
This study will be a randomized, vehicle-controlled, double-masked, multiple-dose, parallel-group study to evaluate the efficacy, safety and tolerability of repeat dosing of Cevimeline Ophthalmic Solution compared to the vehicle in subjects with Dry Eye Disease (DED).
100 项与 Biotheravision, Inc. 相关的临床结果
0 项与 Biotheravision, Inc. 相关的专利(医药)
100 项与 Biotheravision, Inc. 相关的药物交易
100 项与 Biotheravision, Inc. 相关的转化医学